QuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors has authorized the repurchase of up to $300 million of shares of QuidelOrtho’s common stock over the next two years.
‘Tesla Set To Access Up To $20B In Revenues From Supercharger Deals, Dan Ives Says’ – Teslarati
https://www.teslarati.com/tesla-tsla-20b-revenue-access-supercharger-nacs-deal-dan-ives/
Tesla (NASDAQ:TSLA) is set to access up to $20 billion in revenues from its recent Supercharger deals with Ford, General Motors,
